### **Overview** Narayana Hrudayalaya Limited (NHL), founded in 2000 by Dr. Devi Prasad Shetty and headquartered in Bengaluru, India, is one of the largest and most respected private healthcare providers in the country. The company operates a network of **45 healthcare facilities**, including 18 owned/operated hospitals, one managed hospital, three heart centers, 21 primary care clinics, and an international facility in the Cayman Islands, with a total bed capacity of **6,164**. As of FY25, it serves over **30 million patients annually**, demonstrating strong scalability across India and strategic global markets. The core philosophy of Narayana Health (NH) is to "disconnect healthcare access from affluence," emphasizing **affordable, high-quality care** through operational excellence, clinical innovation, and digital transformation. NHL has evolved into a vertically integrated healthcare ecosystem, combining **hospital operations, health insurance (NHIL), integrated primary care (NHIC), and proprietary technology platforms (ATHMA, MEDHA, NH Care)**. --- ### **Strategic Focus in Current Period (Nov 2025)** #### **1. International Expansion: Acquisition of Practice Plus Group (PPG) – UK Market Entry** In October 2025, Narayana Hrudayalaya executed a transformative cross-border acquisition, taking full ownership of **Practice Plus Group Hospitals Limited**, the **fifth-largest private hospital network in the UK** and the **fourth-largest NHS provider in secondary care**. - **Transaction Value**: £183 million (~₹2,240 crore), implying a **9.2x EV/EBITDA multiple** for FY25E. - **Financing**: Funded via £150 million in long-term debt (7-year tenor), with no need for pre-closing regulatory approvals. - **Business Snapshot**: - 7 hospitals - 3 surgical centers - 2 urgent treatment centers - 3 musculoskeletal/diagnostic centers - 1 ophthalmology center - **Total: 330 beds** - **FY24 Revenue**: GBP 229 million → **Projected FY25E: GBP 250 million** - **Rationale**: - Leverages NHL’s proven **low-cost, high-throughput model** in a mature, high-reimbursement environment. - Access to **long-term NHS service contracts** with predictable revenue and volumes. - Asset-light operating model focused on **day-care and outpatient procedures**, aligning with NHL’s scalable approach. - Entry into the UK market offers a pathway for **expanding NHL's global managed care model**. - **Synergy Plan**: - Integration of **ATHMA digital platform** to improve patient outcomes, reduce discharge time, and enhance clinical documentation. - Deployment of **employed physician engagement models** and **new clinical offerings**. - Focus on improving **private payer contracting** and attracting self-pay patients through facility upgrades. This acquisition marks a **low-risk, value-accretive international leap**, building on the success of the Cayman Islands venture, and positions Narayana Health as a global player in value-based healthcare delivery. --- #### **2. Domestic Growth & Capacity Expansion** Narayana Health remains firmly committed to capitalizing on India’s underpenetrated and rapidly growing healthcare market. ##### **Greenfield Projects (FY25–FY28)** - **Rajarhat, Kolkata (350 beds)**: Project cost of ₹9,000 million; **on track for FY28 completion**. - **HSR Layout, Bangalore (215 beds)**: ₹4,900 million investment; awaits regulatory approval; expected **FY28 completion**. - **South Bangalore (350 beds)**: Expansion underway; target **FY29**. - **Raipur Expansion (300 beds)**: ₹5,400 million; expected **FY28**. - **Central Bangalore (220 beds)**: Lease-based project at ₹1,600 million; under construction. > **Total FY25 capex**: ₹5,145 million | **FY26 planned**: ₹4,240 million These expansions are primarily concentrated in **core clusters (Bangalore, Kolkata)** where demand exceeds supply, and existing centers operate at full capacity. ##### **Brownfield & Inorganic Growth** - Acquired **Sparsh Hosur Road Ortho Unit (Bangalore)** in FY23 for ₹2,000 million to strengthen orthopedics at NH Health City. - Continues to evaluate brownfield opportunities and distressed assets in India for synergistic integration. - **Oncology strategy** aims for **20–25% of revenue** within five years through robotic surgery, HIPEC, CAR-T therapy, and new centers. --- #### **3. Clinical & Technological Leadership** Narayana Health maintains a strong position in high-volume, high-complexity specialties: - **Cardiac Sciences**: - Performs **over 16,000 cardiac surgeries annually**, including over 7,000 CABG and 33,500 angiograms. - Leader in **pediatric cardiac surgery and robotic cardiac procedures**. - **Bypass surgery success rate >99%**, exceeding international benchmarks. - **Oncology**: - Offers **end-to-end cancer care**, including CAR-T cell therapy, immunotherapy, LINAC, TrueBeam, and Brachytherapy systems. - Over **2,700 bone marrow transplants**, 7,000+ renal transplants, and 350+ liver transplants performed to date. - Expanding with **three new Radiation Oncology centers** in Kolkata, Shimoga, and Ahmedabad. - **Orthopedics & Spine**: - Growing focus on **robotic joint replacements**, dynamic spine surgery, and specialized trauma care. - Performs over **2,500 joint replacements annually**. - **Neurosciences & Interventional Radiology**: - Conducts over **5,000 neurosurgeries/year**, among India’s highest volumes. - Pioneered **mechanical thrombectomy and AI-powered stroke imaging (RAPID)**. - Over **25,000 image-guided therapy procedures** performed to date. --- #### **4. Digital Transformation & Technology Platforms** Narayana Health has invested heavily in digitization to **increase throughput, reduce costs, and enhance patient outcomes**. - **ATHMA (Hospital Operating System)**: - Fully integrated, cloud-based HIS used across 50%+ of hospitals. - Automates administrative workflows, supports clinical decision-making, and enables paperless operations. - Supports 6,500+ concurrent users, 30,000+ invoices/day, and 700+ admissions/discharges daily. - **MEDHA (AI & Analytics Platform)**: - Developed **NH Score**, a proprietary risk prediction model for cardiac surgery patients using Indian data—outperforms STS and EuroScore II. - Implements **real-time ICU risk scoring**, predictive analytics, and ECG-based cardiac function prediction models. - **Digital Tools**: - **NAMAH (Nursing App)**: Reduced documentation time from >50% to <5% of shifts; saved 5,000+ person-hours. - **AADI (Doctor App)**: Enables real-time monitoring, discharge summary certification (95,000+ processed), and ICU virtual rounds. - **NH Care App**: 200,000+ monthly active users; 500,000+ downloads; 4.8-star rating; supports teleconsultations, e-prescriptions, appointment booking. - **SaaS Aspiration**: - **ATHMA SaaS** launched for Tier II/III hospitals, diagnostic labs, and nursing homes. - Incorporated **Athma Healthtech Pvt Ltd (June 2022)** to commercialize technology products. NHL envisions becoming a **digital-first healthcare provider**, potentially operating "the largest healthcare delivery system without beds" in the future. --- #### **5. Integrated Care & Insurance Verticals** Narayana Health is pioneering an **aligned-care model**, integrating provider and payer roles to enhance trust and outcomes. - **NH Integrated Care (NHIC)**: - Launched Q1 FY24; generated ₹52 million in first quarter with 45,000+ transactions. - Currently expanding in **Bangalore** with new clinics and **Narayana Sarthi**, a dedicated cancer patient support program. - Aims to improve patient access, drive retention, and build **long-term revenue streams**. - **NH Insurance Ltd (NHIL)**: - IRDAI-regulated entity offering two products: - **ADITI**: Affordable inpatient-only plan for the "missing middle." - **ARYA**: Full-spectrum health insurance (inpatient + outpatient), featuring **“walk-in, walk-out” claims** with **no pre-approvals, co-pays, or room rent caps**. - Expansion underway in **Kolkata, Raipur**, and the **Cayman Islands**. - Insurance model is **fully integrated with care delivery**, eliminating claim disputes and aligning incentives. - **₹100 crore invested**; viewed as a strategic anchor for **managed care** innovation in India. --- #### **6. International Strategy & Learnings** - **Cayman Islands Success**: - Flagship facility expanded with **new hospital at Camana Bay**, adding oncology, radiation therapy, and quaternary services. - **EBITDA surged 50% YoY in FY22** to $39.7 million; grew due to domestic Caribbean demand post-pandemic. - Model transitioned from **U.S. medical tourism to local/regional focus**, proving adaptability. - Serves as a **testbed for operating in high-cost, high-reimbursement environments**. - **Caribbean Expansion**: - Ongoing discussions with multiple islands for new contracts. - Conducted consultancy for **St. Lucia’s national hospital**, but declined investment due to poor business climate (profit repatriation, rule of law). - Evaluating incremental entry in **Bahamas (4% stake)**. - **No immediate plans for Africa**; focus remains on **Cayman-like geographies** with stable economies and legal frameworks. - **U.S. Ambitions**: - Long-term aspiration to enter the U.S. market via asset-light or operating models, though no timeline set. --- #### **7. Operational Efficiency & Financial Strategy** - **Cost Leadership**: - Capital cost: ₹1.5–2 crore per bed. - Operates at **lower realization per procedure than peers** but maintains **industry-leading cost efficiency**, enabling 5–10% lower pricing. - **Revenue Mix Optimization**: - Shifting from general wards to **private & semi-private beds** for higher revenue recovery at stable volumes. - Margins improved from **18.3% to 19.4% (Q1 YoY)**, with further upside expected post-capacity ramp-up. - **Working Capital & Payors**: - ~20% revenues from government payors (ECHS, RGHS); payment delays in Q4 FY25 impacted working capital. - **Capital Allocation**: - Disciplined approach: prioritizes **high-return opportunities in India**. - Overseas investments meet high strategic/financial thresholds; **many deals rejected**. - Future growth expected to be **organic (FY26)**, with inflection post-FY28 capacity additions.